Anti-VZV gpII Recombinant Antibody (TI-57) (CAT#: MRO-1157LC)

Figure 1 Detection by anti-h-γ-IgG in the ELISA assay of TI-57 in purified gH:gL artificially contaminated with TI-57.

Theenzyme reaction was terminated before the baseline reactivity of gH:gL and anti-h-γ-IgG became too high to visualize adose–response curve. Mixtures of 500 ng/ml gH:gL and TI-57 at various concentrations from 0n0002% (0n001 ng/ml) to66n7% (1000 ng/ml) were reacted with anti-h-γ-IgG and the mean A values (n l 3) and SD (error bars too small to visualize)are shown.

Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site

Figure 2 Interference of anti-h-IgG in the neutralization of VZV by TI-57.

Cell-free virus without anti-h-IgG treatment () and with 125 µg/ml ofanti-h-IgG ($) was neutralized with various concentrations of TI-57.

Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site